PrEP (Pre-Exposure Prophylaxis) is the use of anti-HIV medications by HIV-negative people to reduce the risk of acquiring HIV.
Taken as prescribed, PrEP is highly effective in stopping the transmission of HIV and allows people to be in control of their HIV status. If PrEP is not taken as prescribed the protection it offers against HIV can be compromised.
PrEP has the potential to make a significant impact on the epidemic and is considered an important new option in the suite of HIV prevention strategies.
GETTING ACCESS TO PrEP
Truvada has been approved by Australia’s Therapeutic Goods Administration (TGA) both for the treatment of people with HIV and for use as PrEP; however the drug has not yet been added to the Pharmaceutical Benefits Scheme for use as PrEP.
AFAO and other HIV organisations are advocating for the PBS listing to occur as soon as possible.
Currently, people wanting to use PrEP can access it through the existing and upcoming clinical trials in Australia; NSW and ACT; Victoria; Queensland; South Australia, Tasmania and Western Australia. People anywhere in Australian can import generic versions of the PrEP through the personal importantion scheme. PrEP can also be purchased from a pharmacist in Australia if an individual has a prescription, however this option is very expensive.